Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950597 · ClinicalTrials.gov registry record
Clinical Impact of Non-invasive Hemodynamic Monitoring
A clinical trial, sponsored by Loma Linda University.
- Completed
- Registry status
- 70
- Enrollment target
NCT02950597: Completed study, sponsored by Loma Linda University.
NCT02950597 is a clinical trial that has completed, run by Loma Linda University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950597 has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Study Details What is the study design? (eg, randomized, double-blind) Observational Prospective Study What are the overall objectives of the study? This project is designed to assess the feasibility of using a non-invasive hemodynamic monitoring device in heart failure outpatient clinics. There will be no alteration to patient management for this study. Rather this study seeks to assess the utility of the device by evaluating for the parameters obtained from the device to hospital admission. How your research will contribute to the advancement of scientific knowledge? ☒This study will confirm/strengthen existing knowledge. ☒This study will test a completely novel hypothesis. ☒This study will explore novel endpoints. ☐Other \[please describe\]:
Interventions
- DEVICE Observational Study to Evaluate Utility of Non-invasive Hemodynamic Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-09-19 |
| Est. Completion | 2019-11-19 |
What the finished NCT02950597 record still lists
NCT02950597 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational Study to Evaluate Utility of Non-invasive Hemodynamic Monitoring is the first listed.
NCT02950597 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02950597 about?
NCT02950597 is a clinical study titled "Clinical Impact of Non-invasive Hemodynamic Monitoring". Study Details What is the study design? (eg, randomized, double-blind) Observational Prospective Study What are the overall objectives of the study? This project is designed to assess the feasibility of using a non-invasive hemodynamic monitoring device in heart failure outpatient clinics. There w...
What is the current status of trial NCT02950597?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2016-09-19. Estimated completion is 2019-11-19.
What interventions are being tested in trial NCT02950597?
The interventions under investigation include: Observational Study to Evaluate Utility of Non-invasive Hemodynamic Monitoring (DEVICE).
Who is sponsoring clinical trial NCT02950597?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI